Full Breakdown
Christina Applegate’s MS Misdiagnosis Highlights Ongoing Diagnostic Challenges
By Drooid · · How we work
Core Event
On October 20, 2026, actress Christina Applegate announced on her “MeSsy” podcast that doctors have concluded she does not have multiple sclerosis (MS), overturning the diagnosis she received in 2021. Applegate described the moment her physician entered the exam room and said, “Congratulations, you don’t have MS,” and explained that the news left her “back at square one” because her debilitating symptoms persisted.
Background & Context
Applegate first disclosed an MS diagnosis in August 2021 after experiencing numbness in her toes that progressed up her legs, severe stabbing pain, and mobility loss that required a wheelchair on the set of *Dead to Me*. She underwent brain and spinal MRIs, a lumbar puncture, and was treated with disease-modifying infusions for several years. In early 2024 her neurologist paused the infusions to monitor B-cell counts; the lack of change prompted a re-evaluation using newer MRI techniques, which ultimately led to the revised assessment.
Data & Statistics
- Dr. Michael Kornberg (Johns Hopkins) estimates that 5 %–10 % of patients diagnosed with MS are later found to have been misdiagnosed.
- Dr. Marwa Kaisey (Cedars-Sinai) cites research indicating that ? 15 %–20 % of people told they have MS do not actually meet diagnostic criteria.
- A 2024 meta-analysis reported a pooled misdiagnosis rate of ? 15 %.
- Earlier analyses have produced a wide range, with some estimates as high as 40 % in specialty clinics.
Official Statements & Responses
- Dr. Michael Kornberg explained that MS lacks a single definitive test; diagnosis relies on typical neurologic symptoms, MRI lesions, and sometimes spinal-fluid analysis, which can overlap with other conditions.
- Dr. Marwa Kaisey emphasized that “MS misdiagnoses are fairly common” because there is “no single test for MS.”
- Dr. Robert Bermel (Cleveland Clinic) noted that misdiagnoses often arise when brain-lesion interpretations are mistaken and that advanced MRI sequences can help differentiate MS from mimicking disorders.
- Dr. Elena Grebenciucova (Northwestern Medicine) reported that 15 %–20 % of patients diagnosed with MS are later found not to have the disease, underscoring the need for second opinions.
Why It Matters / Impact
Applegate’s case illustrates how a high-profile misdiagnosis can affect patient well-being and public perception. Misdiagnosed patients may receive immunosuppressive therapies that carry infection risks and side-effect burdens without addressing the true underlying condition. The emotional toll is evident in Applegate’s description of a “great depression” and feeling she has “let everybody down” after serving as a public “poster child” for MS. Accurate diagnosis is therefore critical for directing appropriate treatment, avoiding unnecessary medication, and providing patients with a clear management plan.
Conflicting Reports & Gaps
Sources differ on the exact prevalence of MS misdiagnosis:
- PBS cites a range of 5 %–40 % across studies.
- Vox references a meta-analysis estimating ? 15 %.
- CBS News and multiple specialist statements converge on ? 15 %–20 %.
The disparity reflects variations in study populations (referral centers vs. general clinics) and evolving diagnostic criteria. No source currently identifies the specific condition responsible for Applegate’s ongoing symptoms.